Vascular endothelial growth factor A (VEGF-A) mRNA expression levels decrease after menopause breast tissue but not in breast cancer lesions

British Journal of Cancer

Volumn 81, Issue 2, 1999, Pages 225-231

  Greb, R R ^a   Maier, I ^a   Wallwiener, D ^a   Kiesel, L ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Angiogenesis; Breast cancer; Menopause; Steroid hormones; VEGF

Indexed keywords

MESSENGER RNA; STEROID HORMONE; VASCULOTROPIN;

AGE; ANGIOGENESIS; ARTICLE; BREAST; BREAST CANCER; BREAST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MENOPAUSE; MICROVASCULATURE; PHENOTYPE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGING; BREAST; BREAST NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MENOPAUSE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; NUCLEIC ACID HYBRIDIZATION; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032830536     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690681     Document Type: Article

References (33)

1. Anan K, Morisaki T, Katano M, Ikubo A, Kitsuki H, Uchiyama A, Kuroki S, Tanaka M and Torisu M (1996) Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery 119: 333-339
2. Beatson GT (1896) On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet ii: 104-107
3. Benoy I, Vermeulen P, Wuyts H and Dirix I. (1998) Vascular endothelial cell growth factor (VEGF) serum concentrations change according to the phase of the menstrual cycle. Eur J Cancer 34: 1298-1299
4. Bini L, Magi B, Marzocchi B, Arcuri F, Tripodi S, Cintorino M, Sanchez JC, Frutiger S, Hughes G, Pallini V, Hochstrasser DF and Tosi P (1997) Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis 18: 2832-2841
5. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL and Schnitt SJ (1995) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 26: 86-91
6. Buadu LD, Murakami J, Murayama S, Hashiguchi N, Sakai S, Masuda K, Toyoshima S, Kuroki S and Ohno S (1996) Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 200: 639-649
7. Chung HC, Rha SY, Ahn JB, Shim KY, Yoo NC, Kim JH, Roh JK, Lee KS, Min JS, Kim BS and Kim JJ (1998) Menstrual state should be considered in determining sero-positivity of soluble angiogenic factors in breast cancer. Int J Mol Med 2: 465-470
8. Dickson RB (1992) Regulation of tumor-host interactions in breast cancer. J Steriod Biochem Mol Biol 41: 389-400
9. Ferrara N and Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25
10. Gasparini G, Toi M, Gion M, Verderio P, Dittadi R, Hanatani M, Matsuhara I, Vinante O, Bonoldi E, Boracchi P, Gatli C, Suzuki H and Tominaga T (1997) Prognostic significance of vascular endothelial growth factor protein in node negative breast carcinoma. J Natl Cancer Inst 89: 139-147
11. Gimbrone MA Jr, Leapman SB, Cotran RS and Folkman J (1972) Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136: 261-276
12. Graven KK, McDonald RJ and Farber HW (1998) Hypoxic regulation of endothelial glyceraldehyde-3-phosphate dehydrogenase. Am J Physiol 274: C347-355
13. Greb RR, Heikinheimo O, Williams RF, Hodgen GD and Goodman AI. (1997) Vascular endothelial growth factor in primate endometrium is regulated by oestrogen receptor and progesterone receptor ligands in vivo. Hum Reprod 12: 1280-1292
14. Hagen AA and Hrushesky WJM (1998) Menstrual timing of breast cancer surgery. Am J Surg 175: 245-261
15. Hanahan D and Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364
16. Heer K, Kumar H, Speirs V, Greenman J, Drew PJ, Fox JN, Carleton PJ, Monson JRT and Kerin MJ (1998) Vascular endothelial growth factor in premenopausal women: indicator of the best time for breast cancer surgery? Br J Cancer 78: 1203-1207
17. Hlatky L, Tsionou C, Hahnfeldt P and Coleman CN (1994) Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Cancer Res 54: 6083-6086
18. Hyder SM, Murthy L and Stancel GM (1998) Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer Res 58: 392-395
19. Le-Bihan S, Marsand V, Mereier-Bodard C, Baulieu EE, Mader S, White JH and Renoir JM (1998) Caleium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inbibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells. Mol Endocrinol 12: 986-1001
20. Müller-Schimpfle M, Ohmenhäuser K, Stoll P, Dietz K and Claussen CD (1997) Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 203: 145-149
21. Mukhopadhyay D, Tsiokas L and Sukhatme VP (1995) Wild-type p53 and v-sre exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 55: 6161-6165
22. Nakamura J, Savinov A, Lu Q and Brodie A (1996) Estrogen regulates vascular endothelial growth permeability factor expression in 7,12-dimethylbenz(a)anthracene induced rat mammary tumors. Endocrinology 137: 5589-5596
23. Obermair A, Kucera E, Mayerhofer K, Speiser P, Seifert M, Czerwenka K, Kaider A, Leodolter S, Kainz C and Zeillinger R (1997) Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease free survival. Int J Cancer 74: 455-458
24. Pham CD, Roberts TPL, vanBruggen N, Melnyk O, Mann J, Ferrara N, Cohen RL and Brasch RC (1998) Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest 16: 225-230
25. Rak J, Filmus J and Kerbel RS (1996) Reciprocal paracrine interactions between tumour cells and endothelial cells: the angiogenesis progression hypothesis. Eur J Cancer 32A: 2438-2450
26. Scott PAE, Gleadle JM, Bicknell R and Harris AL (1998a) Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. Intern J Cancer 75: 706-712
27. Scott PAE, Smith K, Poulsom R, Debenedetti A, Bicknell R and Harris AL (1998b) Differential expression of vascular endothelial growth factor MRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E. Br J Cancer 77: 2120-2128
28. Toi M, Inada K, Suzuki H and Tominaga T (1995) Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 36: 193-204
29. Villena Heinsen C, Ertan AK, Hollander M, Konig J, Tossounidis I and Schmidt W (1998) Diagnostic and predictive ranking of the vascular resistance index in breast tumours. Ultraschall in der Medizin 19: 10-15
30. Vogel PM, Georgiade NG, Fetler BF, Vogel FS and McCarty KS Jr (1981) The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol 104: 23-34
31. Wright PS, Cross-Doersen DE, Chmielewski PA, Bush TL, Bitonti AJ and Miller JA (1995) Measurement of mRNA levels in tumor xenografts with quantitative autoradiography and in situ hybridization. FASEB J 9: 279-283
32. Wright PS, Loudy DE, Cross-Doersen DE, Montgomery LR, Sprinkle-Cavallo J, Miller JA, Distler CM, Lower EE and Woessner RD (1997) Quantitation of vascular endothelial growth factor mRNA levels in human breast tumors and metastatic lymph nodes. Exp Mol Pathol 64: 41-51
33. Yoshiji H, Gomez DE, Shibuya M and Thorgeirsson UP (1996) Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res 56: 2013-2016